Dupilumab Treatment Reduces Total IgE Levels in Patients 6 Months and Older with Moderate-to-Severe Atopic Dermatitis

被引：0
|
作者：
Siegfried, Elaine [1 ]
Cork, Michael [2 ]
Boguniewicz, Mark [3 ]
Deleuran, Mette [4 ]
Simpson, Eric [5 ]
Chen, Zhen [6 ]
Clearfield, Drew [6 ]
Shah, Parul [7 ]
Rodriguez-Marco, Ainara [8 ]
机构：
[1] St Louis Univ, St Louis, MO USA
[2] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
[3] Natl Jewish Hlth, Denver, CO USA
[4] Aarhus Univ Hosp, Aarhus, Denmark
[5] Oregon Hlth & Sci Univ, Portland, OR USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Regeneron, Tarrytown, NY USA
[8] Sanofi, Paris, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
456
引用
收藏
页码：AB149 / AB149
页数：1
相关论文
共 50 条
  • [41] 411 Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [42] Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Vass, Maria
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62
  • [43] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [44] Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment
    Linares-Gonzalez, Laura
    Lozano-Lozano, Ignacio
    Gutierrez-Rojas, Luis
    Ruiz-Villaverde, Ricardo
    Lozano-Lozano, Mario
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 607 - 610
  • [45] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [46] Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van Luijk, C. M.
    Bakker, D. S.
    Ariens, L. F. M.
    Thijs, J. L.
    Van der Schaft, J.
    De Boer, J. H.
    Knol, E. F.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 714 - 714
  • [47] Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients
    Dal Bello, Giacomo
    Maurelli, Martina
    Schena, Donatella
    Girolomoni, Giampiero
    Gisondi, Paolo
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [48] Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis
    Marcant, P.
    Balaye, P.
    Merhi, R.
    Jendoubi, F.
    Nosbaum, A.
    Raison-Peyron, N.
    Du-Thanh, A.
    Lasek, A.
    Ferrier le Bouedec, M. -C.
    Tetart, F.
    Valois, A.
    Barbarot, S.
    Soria, A.
    Jachiet, M.
    Staumont-Salle, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (06) : E394 - E396
  • [49] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    Hamilton, Jennifer D.
    Suarez-Farinas, Mayte
    Dhingra, Nikhil
    Cardinale, Irma
    Li, Xuan
    Kostic, Ana
    Ming, Jeffrey E.
    Radin, Allen R.
    Krueger, James G.
    Graham, Neil
    Yancopoulos, George D.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
  • [50] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
12345